Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.
Gut
; 64(5): 765-75, 2015 May.
Article
in En
| MEDLINE
| ID: mdl-25011937
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Crohn Disease
/
Th2 Cells
/
Th17 Cells
/
Molecular Targeted Therapy
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Gut
Year:
2015
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
United kingdom